OTCMKTS:CNTTF - CannTrust Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous Close$6.08Today's Range$5.95 - $6.1852-Week Range$4.35 - $11.9736Volume2.08 million shsAverage VolumeN/AMarket Capitalization$771.17 millionP/E Ratio85.43Dividend YieldN/ABeta4.52 ProfileAnalyst RatingsChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email CannTrust Holdings Inc. produces and distributes pharmaceutical grade medical cannabis products in Canada. It sells dried cannabis and oil extractions to the client based on the medication document provided by health care practitioner. The company has a partnership with Gold Coast University Hospital. CannTrust Holdings Inc. was incorporated in 2015 and is headquartered in Vaughan, Canada. Receive CNTTF News and Ratings via Email Sign-up to receive the latest news and ratings for CNTTF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CNTTF Previous Symbol CUSIPN/A CIKN/A Webhttp://canntrust.ca/ Phone64-7872-2300Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E Ratio85.43 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$15.96 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares105,640,000Market Cap$771.17 million Next Earnings DateN/A OptionableNot Optionable CannTrust (OTCMKTS:CNTTF) Frequently Asked Questions What is CannTrust's stock symbol? CannTrust trades on the OTCMKTS under the ticker symbol "CNTTF." What is the consensus analysts' recommendation for CannTrust? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CannTrust in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CannTrust. Has CannTrust been receiving favorable news coverage? Headlines about CNTTF stock have been trending positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CannTrust earned a media sentiment score of 2.6 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. Who are some of CannTrust's key competitors? Some companies that are related to CannTrust include FibroGen (FGEN), Agios Pharmaceuticals (AGIO), Amicus Therapeutics (FOLD), Biohaven Pharmaceutical (BHVN), Mirati Therapeutics (MRTX), Reata Pharmaceuticals (RETA), Arena Pharmaceuticals (ARNA), Intercept Pharmaceuticals (ICPT), The Medicines (MDCO), Amneal Pharmaceuticals (AMRX), Uniqure (QURE), PTC Therapeutics (PTCT), Myokardia (MYOK), Emergent Biosolutions (EBS) and Ligand Pharmaceuticals (LGND). What other stocks do shareholders of CannTrust own? Based on aggregate information from My MarketBeat watchlists, some companies that other CannTrust investors own include Canopy Growth (CGC), KushCo (KSHB), Aurora Cannabis (ACB), Cronos Group (CRON), TherapeuticsMD (TXMD), OrganiGram (OGRMF), NVIDIA (NVDA), Aphria (APHA), Aurora Cannabis (ACBFF) and GW Pharmaceuticals PLC- (GWPH). Who are CannTrust's key executives? CannTrust's management team includes the folowing people: Mr. Eric Paul, Co-Founder & Chairman (Age 78)Mr. Brad Rogers, Pres (Age 49)Mr. Ian Abramowitz, Chief Financial Officer (Age 64)Mr. Peter Ralph Aceto, Chief Exec. OfficerMr. Stanley Abramowitz, Sec. (Age 59) How do I buy shares of CannTrust? Shares of CNTTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. How big of a company is CannTrust? CannTrust has a market capitalization of $0.00 and generates $15.96 million in revenue each year. What is CannTrust's official website? The official website for CannTrust is http://canntrust.ca/. How can I contact CannTrust? CannTrust's mailing address is 3280 Langstaff Road Building 1, Vaughan A6, L4K 5B6. The company can be reached via phone at 64-7872-2300 or via email at [email protected] MarketBeat Community Rating for CannTrust (OTCMKTS CNTTF)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 70 (Vote Outperform)Underperform Votes: 42 (Vote Underperform)Total Votes: 112MarketBeat's community ratings are surveys of what our community members think about CannTrust and other stocks. Vote "Outperform" if you believe CNTTF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CNTTF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/24/2019 by MarketBeat.com StaffFeatured Article: Net Income Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.